Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PET100 pseudogene 1 (PET100P1) is a **pseudogene** related to the functional gene PET100, which encodes a chaperone involved in the biogenesis of mitochondrial complex IV, cytochrome c oxidase. Pseudogenes like PET100P1 are genomic regions that originate from functional genes but typically lack protein-coding capacity due to mutations, truncations, or other alterations[1][2][3][4]. The primary PET100 gene is located on chromosome 19; PET100P1 is typically described as a non-functional copy located on chromosome 3[1][3]. Pseudogenes often do not produce a functional protein and are generally not considered druggable or therapeutic targets themselves[2][4]. However, in some cases, selected pseudogenes can exert regulatory influences (such as through non-coding RNA functions or by acting as competing endogenous RNAs), but there is currently no evidence PET100P1 has such a role[2][4][5]. No known drugs, clinical biomarkers, therapeutic mechanisms, or disease associations specific to PET100P1 exist. The inclusion of “pseudogene” in the name and lack of protein-coding evidence suggest PET100P1 is **not a therapeutic target** and would generally not be referenced as such in biomedical research. If the intention was to refer to the functional protein-coding PET100 gene, the correct canonical name would be “PET100 cytochrome c oxidase chaperone” (abbreviation: PET100)[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PET100 pseudogene 1 (PET100P1).